ClinicalTrials.gg
Sign In

Hyperopia clinical trials

The registry lists 156 studies for Hyperopia across more than 10 countries. 20 are recruiting or about to start. 42 of them are mainly about Hyperopia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Hyperopia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
97
Status unknown
18
Terminated
12
Not yet recruiting
10
Recruiting
8
Withdrawn
5

Phase

Phase 4
11
Phase 2
7
Phase 3
6
Phase 1
6
Early Phase 1
1

Where

United States
68
Canada
13
China
11
United Kingdom
8
Spain
6
France
6

Who runs them

Alcon Research (22) · CooperVision International Limited (CVIL) (11) · Technolas Perfect Vision GmbH (7) · Eye Hospital Pristina Kosovo (4) · CooperVision, Inc. (4) · Abbott Medical Optics (3) · EyeQue Corp. (3) · Lentechs, LLC (3)

What is being tested here

Drugs under test in Hyperopia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cannabinoids001
Ketorolac001
Nepafenac001
Riboflavin001
Dextrans001
Proxymetacaine001
Prizloncabtagene autoleucel001
Levofloxacin001
Betamethasone001

Coming up

0phase 3 studies under way
7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Who these studies take

Of the 8 Hyperopia studies recruiting now, 3 (38%) set no upper age limit and 5 (63%) stop at 75 or younger. 5 (63%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 6 (75%) take healthy volunteers.

Recruiting studies that take each age, of 8
AgeWomenMen
105 (63%)5 (63%)
182 (25%)2 (25%)
303 (38%)3 (38%)
404 (50%)4 (50%)
504 (50%)4 (50%)
653 (38%)3 (38%)
753 (38%)3 (38%)
853 (38%)3 (38%)

Across all 156 studies, recruiting or not: 40% stop at 75 or younger and 37% at 65; 29% take children; 0% are for women only and 0% for men only; 46% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hyperopia studies take

Of 54 interventional studies with no phase under Hyperopia, half reached primary completion within 10 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase10 mo4–24 · 54 studies5 mo2–24 · 36 studies—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Stopped1

Studies

Recruiting first, then most recently updated. Showing 50 of 156. Browse all 156 → or search them.